| Not Yet Recruiting | Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthr NCT07525856 | CHU de Quebec-Universite Laval | N/A |
| Not Yet Recruiting | A Study of BEN301 Injection in theTreatment of Autoimmune Diseases NCT07527936 | RenJi Hospital | EARLY_Phase 1 |
| Recruiting | Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares NCT07245732 | Sunnybrook Health Sciences Centre | Phase 4 |
| Not Yet Recruiting | Effect of Lavender Aromatherapy Massage on Pain and Wrist Mobility in Rheumatoid Arthritis NCT07456657 | University of Baghdad | N/A |
| Recruiting | Controlling Hyperactive Immunity With Long-lived Lymphocytes NCT07473154 | Quell Therapeutics Limited | Phase 1 / Phase 2 |
| Not Yet Recruiting | Efficacy of Structured Progressive Training Exercise on Muscle Strength of Patients With Rheumatoid Arthritis NCT07487779 | Kufa University | N/A |
| Recruiting | Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic D NCT07087912 | University of Sao Paulo General Hospital | Phase 4 |
| Recruiting | A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA). NCT07234773 | Kali Therapeutics, Inc. | Phase 1 |
| Not Yet Recruiting | QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis NCT07377773 | Qilu Pharmaceutical Co., Ltd. | Phase 2 |
| Not Yet Recruiting | Kinesiophobia in Rheumatoid Arthritis: Associations With Functional Disability, Disease Activity, and Related NCT07435272 | Minia University | — |
| Not Yet Recruiting | Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid A NCT07393217 | Sohag University | — |
| Recruiting | Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis NCT07524244 | Fuller Research Foundation | N/A |
| Not Yet Recruiting | Effect of Subthreshold Stimulation on Fatigue in Rheumatoid Arthritis NCT07367438 | Beni-Suef University | N/A |
| Recruiting | Dysphagia in Rheumatoid Arthritis NCT07401732 | Tanta University | — |
| Not Yet Recruiting | Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine NCT07416656 | Klavs Würgler Hansen | — |
| Not Yet Recruiting | Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578 | Seismic Therapeutic AU Pty Ltd | Phase 1 |
| Recruiting | Effect of Mediterranean vs Paleolithic Diet on RA Activity, Sarcopenia and QOL: 12-Week RCT NCT07438652 | Kasr El Aini Hospital | N/A |
| Not Yet Recruiting | Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases NCT07329556 | Bursa City Hospital | — |
| Recruiting | Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being NCT07222696 | Weill Medical College of Cornell University | N/A |
| Recruiting | Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis NCT07347860 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | EARLY_Phase 1 |
| Recruiting | A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis NCT07245992 | Philogen S.p.A. | Phase 1 |
| Not Yet Recruiting | Anti-citrullinated SR-A Peptide (Anti-csp) Antibody as a Biomarker in Rheumatoid Arthritis (RA). NCT07147127 | Walaa sharif Eid Ahmed | — |
| Not Yet Recruiting | Pain Neuroscience Education and Vagus Nerve Stimulation on Recovery in Individuals With Rheumatoid Arthritis NCT07274124 | Medipol University | N/A |
| Recruiting | Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis NCT07293871 | Surf Therapeutics | Phase 2 |
| Recruiting | Plant-Based Diet for Patients With Rheumatoid Arthritis NCT07268326 | Center for Clinical Research and Prevention | N/A |
| Recruiting | Validity And Reliability Of The Four Square Step Test In Individuals With Rheumatoid Arthritis NCT07264101 | Inonu University | — |
| Recruiting | A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis NCT07258849 | Eli Lilly and Company | Phase 1 |
| Not Yet Recruiting | Comparison of Glucocorticoid Tapering Schedules in Rheumatoid Arthritis NCT07227428 | Seoul National University Hospital | Phase 4 |
| Not Yet Recruiting | Rehabilitation Exercise Intervention for Rheumatoid Arthritis Patients Using Artificial Intelligence-Based Exe NCT07246811 | Peking University Third Hospital | N/A |
| Recruiting | A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 NCT07403188 | Kyverna Therapeutics | — |
| Recruiting | Probiotics in Adults With Rheumatoid Arthritis NCT07304505 | Ancilia Biosciences | N/A |
| Active Not Recruiting | A Trial of Academic Detailing to Promote Prescribing of Biosimilars NCT07221890 | Brigham and Women's Hospital | N/A |
| Recruiting | At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study] NCT07163221 | SecondWave Systems Inc. | N/A |
| Not Yet Recruiting | Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission NCT06783322 | Diakonhjemmet Hospital | — |
| Recruiting | A Phase 1 Study of ADI-001 in Rheumatoid Arthritis NCT07100873 | Adicet Therapeutics | Phase 1 |
| Recruiting | The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects NCT07200596 | Guangdong Hengrui Pharmaceutical Co., Ltd | Phase 1 |
| Recruiting | Oxidative Stress in Autoimmune Rheumatic Diseases NCT07536529 | University of Thessaly | — |
| Not Yet Recruiting | Investigation Of The Effects Of Anti-Tnf-Α And Non-Tnf-Α Drugs İn Patients With Rheumatoid Arthritis NCT07182630 | Firat University | — |
| Not Yet Recruiting | "Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease" NCT07173582 | Assiut University | — |
| Not Yet Recruiting | National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis NCT06876064 | University Hospital, Montpellier | — |
| Recruiting | Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis NCT07301892 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | — |
| Not Yet Recruiting | Mass Spectrometry-based Immune Profiling in Autoimmune Diseases NCT07188285 | Peking University People's Hospital | — |
| Recruiting | REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases NCT07160231 | Sint Maartenskliniek | Phase 4 |
| Recruiting | Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis NCT06812481 | Balikesir University | — |
| Recruiting | Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis NCT07408024 | Toll Biotech Co. Ltd. (Beijing) | Phase 2 |
| Not Yet Recruiting | Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis NCT06933134 | University Hospital, Tours | — |
| Not Yet Recruiting | The Effect of Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis NCT06881966 | Hopital Charles Nicolle | N/A |
| Recruiting | Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western M NCT07484243 | Yuanyuan Zhang | — |
| Recruiting | Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants NCT07182656 | Yi Fang | Phase 1 |
| Not Yet Recruiting | A Study of Iguratimod in Combination With Tofacitinib in RA Patients NCT06945666 | Jie Chang | Phase 4 |
| Recruiting | A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Reg NCT07123038 | Sonoma Biotherapeutics, Inc. | — |
| Recruiting | Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With R NCT06906549 | University Hospital, Strasbourg, France | Phase 4 |
| Recruiting | AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Ritux NCT06991114 | Artiva Biotherapeutics, Inc. | Phase 2 |
| Not Yet Recruiting | Personalized Outreach for Equitable Treatment in Rheumatology NCT07022756 | University of British Columbia | N/A |
| Active Not Recruiting | This Study Aims to Characterize and Compare Patients of Adult-onset RA With Patients of Elderly-onset RA Based NCT07069088 | Sohag University | — |
| Recruiting | Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumato NCT07034196 | St. Lawrence Health System | N/A |
| Recruiting | An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis NCT06946199 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 |
| Recruiting | An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis NCT07013110 | Prof Salvatore Albani | Phase 2 |
| Not Yet Recruiting | Telitacicept for the Treatment of Refractory RA NCT07008196 | Chinese SLE Treatment And Research Group | Phase 4 |
| Completed | Cardiovascular Disease Awareness in Rheumatoid Arthritis and Knee Osteoarthritis NCT07056608 | Sisli Hamidiye Etfal Training and Research Hospital | — |
| Not Yet Recruiting | Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection NCT06982547 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | EARLY_Phase 1 |
| Completed | Bone Density Change in Postmenopausal Rheumatoid Arthritis NCT07336693 | Istanbul University - Cerrahpasa | — |
| Recruiting | The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection NCT07001956 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | EARLY_Phase 1 |
| Not Yet Recruiting | Therapy of Niacin for Rheumatoid Arthritis NCT07004725 | Peking University People's Hospital | Phase 2 |
| Recruiting | A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647 | China Immunotech (Beijing) Biotechnology Co., Ltd. | Phase 1 |
| Recruiting | A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Ar NCT06994143 | Cullinan Therapeutics Inc. | Phase 1 |
| Completed | Prediction of Pulmonary Problems NCT07047391 | Zülal TATAR | — |
| Recruiting | Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis NCT07138729 | Luo Yaping | N/A |
| Recruiting | HiSCs in the Treatment of Rheumatoid Arthritis NCT06947746 | Shanghai Changzheng Hospital | N/A |
| Recruiting | Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS NCT06913907 | Keio University | Phase 4 |
| Enrolling By Invitation | Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis NCT06726096 | Beijing VDJBio Co., LTD. | Phase 3 |
| Recruiting | Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy NCT07150000 | University of Bonn | — |
| Recruiting | A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Mod NCT06946641 | Shanghai Qilu Pharmaceutical Research and Development Center LTD | Phase 1 |
| Completed | Feasibility and Acceptability of PREVAIL (PREserving Valued Activities In Life) NCT06706999 | University of North Carolina, Chapel Hill | N/A |
| Recruiting | Dose Response of Exercise for Arthritis Management NCT06880653 | University of South Carolina | N/A |
| Recruiting | A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Disease NCT06647069 | Sanofi | Phase 1 |
| Recruiting | Treatment With Auricular Vagus Nerve Stimulation in Rheumatoid Arthritis - the TRAVAGA Study NCT06779123 | taVNS AB | N/A |
| Recruiting | Could a Feedback Device Help Manage Work-related Shoulder Disorders? NCT06693479 | Laval University | N/A |
| Enrolling By Invitation | Nutrition in Rheumatoid Arthritis NCT06831331 | Vastra Gotaland Region | N/A |
| Recruiting | An Alternative Assessment in Patients with Rheumatoid Arthritis: 6 Minute Step Test NCT06838884 | Firat University | N/A |
| Recruiting | L-carnitine Supplementation in Rheumatoid Arthritis Patients NCT06753565 | German University in Cairo | Phase 2 |
| Completed | Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetic, and Food Effects of ARD-885 Film-coated Table NCT07266207 | Artivila (Shenzhen) Innovation Center, Ltd | Phase 1 |
| Recruiting | Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis NCT06628206 | LAPIX Therapeutics Inc. | Phase 1 |
| Not Yet Recruiting | The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity on Diabetic Patients NCT06691997 | Assiut University | — |
| Not Yet Recruiting | Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate NCT06724952 | Tanta University | Phase 4 |
| Active Not Recruiting | The Effect of Cold Application in Patients With Rheumatoid Arthritis NCT07359326 | Saglik Bilimleri Universitesi | N/A |
| Recruiting | COVID-19 Booster and IIV Schedule in Immunocompromised Hosts NCT06599658 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 |
| Recruiting | AYLo - AutoimmunitY and Loss of y NCT06696027 | University of Bonn | — |
| Recruiting | Safety Study of CC312 in Autoimmune Disease Patients NCT06888960 | CytoCares Inc | EARLY_Phase 1 |
| Not Yet Recruiting | The Possible Efficacy and Protective Effect of Empagliflozin in Rheumatoid Arthritis Patients Treated with Met NCT06641128 | Tanta University | Phase 4 |
| Recruiting | A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimil NCT06596772 | mAbxience Research S.L. | Phase 3 |
| Completed | Integrated Care Approach for Rheumatoid Arthritis Patients NCT06791980 | Dalin Tzu Chi General Hospital | N/A |
| Recruiting | COMFI - a COMbined Fatigue Intervention NCT06666452 | The Danish Center for Expertise in Rheumatology | N/A |
| Recruiting | A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Ant NCT06671054 | SynAct Pharma Aps | Phase 2 |
| Recruiting | The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study NCT07315997 | Brigham and Women's Hospital | — |
| Recruiting | A RWS of SC MTX in Chinese RA Patients NCT07463937 | Peking University People's Hospital | — |
| Not Yet Recruiting | Use of Thermography for the Prevention and Diagnosis of Rheumatic Foot NCT06515769 | University of Seville | — |
| Recruiting | Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases NCT07085676 | Polina Stepensky | Phase 1 |
| Recruiting | Efficacy Of Upadacitinib In Psoriatic Arthritis And Comparison To Rheumatoid Arthritis. NCT06630715 | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | — |
| Completed | Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunog NCT06929039 | Kashiv BioSciences, LLC | Phase 1 |
| Active Not Recruiting | Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults NCT06614166 | Solarea Bio, Inc | N/A |
| Recruiting | Comparative Effectiveness of Different Drugs Used to tr€at Patients in Rheumatoid Arthritis Saudi Database (RA NCT06417138 | Umm Al-Qura University | — |
| Recruiting | Rheumatoid Arthritis and Osteosarcopenia: Associated Factors NCT06889415 | Konya Beyhekim Training and Research Hospital | — |
| Completed | The Effect of the Ideal Food Pyramid on Rheumatoid Arthritis NCT06621927 | TC Erciyes University | N/A |
| Completed | The Effects of Kinesiophobia and Proprioception on Disability and Function in Rheumatoid Hand NCT07141927 | Cumhuriyet University | — |
| Completed | Phase I Clinical Study of ZL-82 Tablets NCT06055023 | Chengdu Zenitar Biomedical Technology Co., Ltd | Phase 1 |
| Completed | Screening Anxiety and Depression Among Patients with Chronic Musculoskeletal Pain Within Physiotherapy Practic NCT06785883 | KU Leuven | — |
| Recruiting | Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity NCT07277491 | Cairo University | — |
| Unknown | Expression of IRAK1 Gene rs1059703-related Single- Nucleotide Polymorphisms in Egyptian Patient With Rheumatoi NCT05588817 | Sohag University | N/A |
| Unknown | Vitamin d Level and it's Association With Disease Activity in Egyptian Rheumatoid Arthritis Patients NCT05486715 | Mariam Samir Farg | — |
| Terminated | Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design NCT04941729 | Smith & Nephew Medical (Shanghai) Ltd | N/A |
| Completed | A Study of Human Substance Balance and Biotransformation of [14C]SHR0302 NCT05047341 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Terminated | COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders NCT05000216 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Terminated | Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age NCT04888585 | AbbVie | Phase 2 |
| Completed | A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korea NCT04541810 | AbbVie | — |
| Completed | A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Mainte NCT04497597 | AbbVie | — |
| Completed | A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants W NCT04574492 | AbbVie | — |
| Completed | Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheu NCT04340115 | AbbVie | — |
| Completed | An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monother NCT04267536 | AbbVie | — |
| Completed | Poly-L/D-lactide Implant (RegJoint) Versus Tendon Interposition for Trapeziometacarpal Inflammatory Arthritis: NCT06804356 | Helsinki University Central Hospital | N/A |
| Recruiting | Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheu NCT03971253 | Astellas Pharma Inc | — |
| Suspended | A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease NCT04031469 | ProgenaBiome | — |
| Active Not Recruiting | The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis NCT03631225 | Sequenom, Inc. | — |
| Completed | A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database NCT05421442 | Bristol-Myers Squibb | — |
| Terminated | A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in NCT03823378 | AbbVie | Phase 2 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With NCT03823391 | AbbVie | Phase 2 |
| Completed | A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis ( NCT03737708 | Astellas Pharma Korea, Inc. | Phase 4 |
| Completed | Inflammatory Arthritis and Tango NCT03840785 | University Hospital, Clermont-Ferrand | N/A |
| Completed | A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 NCT03682705 | AbbVie | Phase 2 |
| Withdrawn | Changes in Ultrasonographic Assessment of Inflammation Upon Initiation of Adalimumab Combination Therapy in Ch NCT02786563 | AbbVie | — |
| Completed | A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Ina NCT03660059 | Astellas Pharma China, Inc. | Phase 3 |
| Terminated | Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis NCT03410056 | Amgen | Phase 1 / Phase 2 |
| Completed | Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammator NCT03339089 | AbbVie | — |
| Completed | Effectiveness of Yoga and Combined Exercise in Rheumatoid Arthritis NCT07072754 | Izmir Katip Celebi University | N/A |
| Completed | A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely NCT02955212 | AbbVie | Phase 3 |
| Unknown | A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX NCT04312815 | SinoMab BioScience Ltd | Phase 3 |
| Completed | Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in C NCT03223012 | AbbVie | — |
| Completed | A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate NCT03257852 | Astellas Pharma Inc | Phase 2 |
| Completed | Niclosamide With Etanercept in Rheumatoid Arthritis NCT03160001 | Faiq Gorial | Phase 1 / Phase 2 |
| Completed | Use of Acthar in Rheumatoid Arthritis (RA) Related Flares NCT02541955 | Veena Ranganath, MD, MS | Phase 4 |
| Completed | A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of C NCT03086343 | AbbVie | Phase 3 |
| Completed | Efficiency of a Nurse-led Self-management Education Intervention in Promoting Safety Knowledge and Skills of P NCT02855320 | Assistance Publique - Hôpitaux de Paris | N/A |
| Terminated | UCB Cimzia Pregnancy Follow-up Study NCT02775656 | UCB BIOSCIENCES, Inc. | — |
| Unknown | Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously NCT02805010 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 1 |
| Unknown | A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to M NCT02722694 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Effect of Siwan Sand Therapy on Pulmonary Functions of Rheumatoid Arthritis Patients NCT07287696 | Ahram Canadian University | N/A |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Dos NCT02698657 | Astellas Pharma Global Development, Inc. | Phase 1 |
| Terminated | Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Aba NCT02353780 | Dr. Larry W. Moreland | Phase 4 |
| Completed | A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523 NCT02105129 | Hutchison Medipharma Limited | Phase 1 |
| Unknown | Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients NCT01915537 | Zhang, Xiao, M.D. | N/A |
| Terminated | Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis T NCT01691014 | Pfizer | — |
| Unknown | Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheu NCT01835613 | Osservatorio Epidemiologico GISEA | Phase 4 |
| Completed | Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis NCT01871961 | medac GmbH | Phase 1 |
| Terminated | Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite NCT01569152 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis ( NCT01577563 | AstraZeneca | — |
| Completed | Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device NCT01618955 | Antares Pharma Inc. | Phase 2 |
| Completed | Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device NCT01618968 | Antares Pharma Inc. | Phase 2 |
| Terminated | Masitinib in Refractory Active Rheumatoid Arthritis NCT01410695 | AB Science | Phase 2 / Phase 3 |
| Completed | Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis NCT01258712 | Chugai Pharma Taiwan | Phase 3 |
| Completed | Methotrexate - Inadequate Response Device Sub-Study NCT01173120 | Bristol-Myers Squibb | Phase 3 |
| Completed | EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondyl NCT01078402 | AbbVie (prior sponsor, Abbott) | — |
| Completed | Methotrexate-Inadequate Response Study NCT00559585 | Bristol-Myers Squibb | Phase 3 |
| Completed | Phase IIIB Subcutaneous Abatacept Monotherapy Study NCT00547521 | Bristol-Myers Squibb | Phase 3 |
| Completed | Optimization of Treatment With Adalimumab (Humira) NCT01585064 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Terminated | Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114 NCT00296257 | Dainippon Sumitomo Pharma Europe LTd. | Phase 2 |
| Active Not Recruiting | Dietary Factors and Rheumatoid Arthritis Risk in the UK Biobank NCT06670183 | University of Leeds | — |
| Completed | Diet and Rheumatoid Arthritis Risk in the United Kingdom Women's Cohort NCT06670144 | University of Leeds | — |